Sofituzumab (MMUC 1206A) is a humanized anti-MUC16 recombinant V-kappa antibody[1].
[1]. El Bairi K, et al. Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer. Semin Cancer Biol. 2021 Dec;77:42-55.
















